Pitt Receives 4.7 Million Award From Tobacco Settlement Money To Shorten Hospital-Acquired Infections
The University of Pittsburgh College of Medicine has received a four-year, $4.7 million grant from the Pennsylvania Branch of Health to boast distinct ways to barricade lethal hospital-acquired infections that frequently are resistant to treatment. The grant, funded by Pennsylvania's help of the civic 2008-2009 tobacco settlement, testament hub on C. difficile, A. baumanniiand the drug-resistant bacteria acknowledged as MRSA, which beginning tens of thousands of deaths in the U.S. every year.
"Infections that are resistant to antibiotics are fitting more and more problematic not onliest in the United States, on the contrary sorrounding the world," said Shelter Harrison, M.D., principal investigator of the grant and professor of medicine and epidemiology, University of Pittsburgh. "We not lone devoir to maturate advanced drugs, on the other hand and to edit infection surveillance and focal point on targeted interventions."
The grant will enable investigators to enact a Centre of Excellence in Prevention and Authority of Antibiotic-Resistant Bacterial Infections at the University of Pittsburgh, and will combine partnerships with various UPMC hospitals, Carnegie Mellon University and Kane Local Centres of Allegheny County.
The project will assess the medical and economic impacts of au courant strategies to prevent and determination hospital-acquired infections, which were diagnosed in 27,000 patients in Pennsylvania in 2007. Patients with these infections were hospitalized three times longer and their admissions were four times as expensive as non-infected patients.
Most bacterial infections can be effectively controlled with existing antibiotic drugs, nevertheless microbial pathogens like C. difficile, A. baumannii and MRSA hold an inherent command to grow narcotic resistence over crowded genetic mechanisms, moulding them chiefly crucial to treat.
Co-investigators on the grant count Scott Curry, M.D., Jo-anne Burge, M.D., Yohei Doi, M.D., Bruce Lee, M.D., and Paula Davis, all with the University of Pittsburgh Institution of Medicine.
The grant was awarded as department of the Commonwealth Regular Trial Enhancement Programme (CURE), which supports clinical, health services and biomedical research, and was one of one four awarded to direction 2008-2009 Health Check Advisory Commitee priorities.
University of Pittsburgh Medical Center, U.S. Steel Tower, 600 Grant St., 57th Floor, Pittsburgh, PA 15213 United States
University of Pittsburgh Medical Center
Last relative articles:
- Tobacco Use Linked To Worse Outcomes In HPV-Positive Head And Neck Cancer, U-M Study Finds
- Quitting Smoking Especially Difficult For Select Groups
- Spanish Language Ads Get Message Across For Smoking Quit Lines
- Study Reveals A Need To Evaluate And Regulate Electronic Cigarettes
- Insufficient Counseling For Obesity And Smoking Due To Cost To Patients
- New TAU Study Proves Smoking Cessation Significantly Increases Cardiac Health Later In Life
- News From The Annals Of Internal Medicine, February 2, 2010
- Decline In Exposure To Secondhand Smoke Among Children In England Since 1996
- Single Payer Bill Passes Calif. Senate; Other States Consider Smaller Health Care Changes
- Most Ex-Smokers Quit Successfully Without Help
infections, shorten infections, infections university, infections pitt, bacterial infections, infections resistant, infections frequently, infections diagnosed, infections effectively, infections hospitalized